Agilent Technologies has appointed Sam Mohan to be Southeast Asia regional manager for its Life Sciences Group. Mohan will be responsible for building and implementing the firm's Southeast Asian product strategies, as well as its lifecycle management, partner integration, global branding, and communications. He formerly was sales director of Cell Biosciences. Before that, he was a manager at Amersham Biosciences (now part of GE Healthcare) and Bio-Rad Laboratories.
Raymond Whitaker will not stand for his position on Fluidigm's board of directors at the firm's next annual stockholder meeting. The company's board also has approved an increase in base salary for President and CEO Gajus Worthington from $319,000 to $350,000.
RainDance Technologies has tapped Andy Watson to serve as its vice president and chief marketing officer. In the role, he will lead marketing and strategy efforts for the company's targeted sequencing business and for the launch of its digital PCR and single cell analysis products.
Watson formerly was VP of SOLiD sequencing product management at Life Technologies. He was also was a founder of Quantum Dot, and he led development of technologies and software for large-scale DNA analysis at Sequana Therapeutics.
Adarza BioSystems has added Heiner Dreismann and James Senall to its board of directors. Dreismann formerly was CEO of Roche Molecular Systems, while Senall formerly served as managing director of business development at the Greater Rochester Enterprise.